(InSilico Medicine, Inc.) Billionaire investor Jim Mellon has announced his commitment to support research in human longevity. He recently made an investment in Insilico Medicine to enable the company to validate the many molecules discovered using deep learning and launch multi-modal biomarkers of human aging.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2oqe21Z
No comments:
Post a Comment